Cargando…
Comparative Benefit–Risk Assessment for Lidocaine 700 mg Medicated Plaster and Pregabalin in Peripheral Neuropathic Pain Following a Structured Framework Approach
INTRODUCTION: Peripheral neuropathic pain (PNP) is difficult to treat. Several oral drugs are recommended as first-line treatments. Nevertheless, many patients cannot obtain sufficient pain relief or do not tolerate systemically active treatments. Topical treatments, with a lower risk of systemic si...
Autores principales: | Sabatschus, Ingo, Bösl, Irmgard, Prevoo, Marlou, Eerdekens, Mariëlle, Sprünken, Arne, Galm, Oliver, Forstner, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861254/ https://www.ncbi.nlm.nih.gov/pubmed/34792789 http://dx.doi.org/10.1007/s40122-021-00340-2 |
Ejemplares similares
-
Painful diabetic peripheral neuropathy: real-world comparison between topical treatment with lidocaine 700 mg medicated plaster and oral treatments
por: Überall, Michael, et al.
Publicado: (2022) -
Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review
por: Plested, Melanie, et al.
Publicado: (2010) -
5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability
por: Navez, Marie Louise, et al.
Publicado: (2015) -
Treatment of localized neuropathic pain after disk herniation with 5% lidocaine medicated plaster
por: Likar, Rudolf, et al.
Publicado: (2012) -
Treatment of localized neuropathic pain of different etiologies with the 5% lidocaine medicated plaster – a case series
por: Likar, Rudolf, et al.
Publicado: (2014)